Biology, Asset Management, Personalized Medicine, Genomics, Future.
long been of interest to institutional investors, my presentation focused on how biology itself is starting to be recognized as an emerging asset class, one that is quite different from traditional asset classes like equities, real estate, and commodities. My thesis is that, as biotechnology